We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 2 of 2 for:    CB-839 lung

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02071862
Recruitment Status : Recruiting
First Posted : February 26, 2014
Last Update Posted : August 22, 2016
Information provided by (Responsible Party):
Calithera Biosciences, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2017
  Estimated Study Completion Date : September 2017